Active Surveillance Study of the Safety of MultiHance®in India.
A Multicenter, Prospective, Non-Comparative, Non-Randomized,Open Label, Phase IV clinical trial to evaluate safety and efficacy ofProHance in patients undergoing Contrast Enhanced MagneticResonance Imaging (CE-MRI) of the whole body during routineclinical practice in India.
A Multicenter, Prospective, Non-Comparative, Non-Randomized, Open Label, Phase IV clinical trial to evaluate safety and efficacy of ProHance in patients undergoing Contrast Enhanced Magnetic Resonance Imaging (CE-MRI) of brain/spine and head and neck during routine clinical practice in India.
100 项与 Imaging Products (India) Pvt Ltd. 相关的临床结果
0 项与 Imaging Products (India) Pvt Ltd. 相关的专利（医药）
100 项与 Imaging Products (India) Pvt Ltd. 相关的药物交易
100 项与 Imaging Products (India) Pvt Ltd. 相关的转化医学
